ChemoMetec A/S (CPH: CHEMM)
Denmark
· Delayed Price · Currency is DKK 432.60
-2.20 (-0.51%)
Nov 19, 2024, 4:59 PM CET
ChemoMetec Revenue
In the fiscal year ending June 30, 2024, ChemoMetec had annual revenue of 407.87M DKK, down -8.22%. ChemoMetec had revenue of 208.07M in the half year ending June 30, 2024, a decrease of -4.81%.
Revenue
407.87M
Revenue Growth
-8.22%
P/S Ratio
19.29
Revenue / Employee
2.34M
Employees
174
Market Cap
7.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 407.87M | -36.53M | -8.22% |
| Jun 30, 2023 | 444.40M | 16.01M | 3.74% |
| Jun 30, 2022 | 428.39M | 147.26M | 52.38% |
| Jun 30, 2021 | 281.13M | 67.03M | 31.31% |
| Jun 30, 2020 | 214.10M | 38.59M | 21.99% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk A/S | 270.58B |
| Coloplast A/S | 27.03B |
| Genmab A/S | 19.84B |
| Demant A/S | 22.84B |
| Zealand Pharma A/S | 76.87M |
| H. Lundbeck A/S | 21.44B |
| H. Lundbeck A/S | 21.44B |
| ALK-Abelló A/S | 5.38B |